Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
about
Of mice, cattle, and humans: the immunology and treatment of river blindnessExpansion and activation of CD4(+)CD25(+) regulatory T cells in Heligmosomoides polygyrus infectionElevated adaptive immune responses are associated with latent infections of Wuchereria bancroftiA research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiasesImmunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levelsResistance and susceptibility to filarial infection with Litomosoides sigmodontis are associated with early differences in parasite development and in localized immune reactionsRiver blindness: a success story under threat?Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule.Immunohistology of ectopic secondary lymph follicles in subcutaneous nodules from patients with hyperreactive onchocerciasis (sowda).Protective immunity to the larval stages of onchocerca volvulus is dependent on Toll-like receptor 4.Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortalityThe chemokine CXCL12 is essential for the clearance of the filaria Litomosoides sigmodontis in resistant miceInduction of immunoglobulin G4 in human filariasis: an indicator of immunoregulationHyperreactive onchocerciasis is characterized by a combination of Th17-Th2 immune responses and reduced regulatory T cells.Synergism of gamma interferon and interleukin-5 in the control of murine filariasis.Genetic variation in immune function and susceptibility to human filariasis.Prevalence of onchocerciasis in the Fundong Health District, Cameroon after 6 years of continuous community-directed treatment with ivermectin.Impairment of dendritic cell function and induction of CD4(+)CD25(+)Foxp3(+) T cells by excretory-secretory products: a potential mechanism of immune evasion adopted by Echinococcus granulosus.Helminth parasites--masters of regulation.Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergyImmunopathology of schistosomiasisImmunomodulation by filarial nematodes.Suppression of allergic airway inflammation by helminth-induced regulatory T cellsNew strategies to combat filariasis.Immune modulation by helminthic infections: worms and viral infections.HIV and helminth co-infection: is deworming necessary?Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.Exploring the immunology of parasitism--from surface antigens to the hygiene hypothesis.Interleukin-10 (IL-10) counterregulates IL-4-dependent effector mechanisms in Murine Filariasis.Future prospects and challenges of vaccines against filariasis.Differential induction of Th2- and Th1-associated responses by filarial antigens and endosymbiotic Wolbachia in a murine model of river blindnessPromoter haplotypes of the interleukin-10 gene influence proliferation of peripheral blood cells in response to helminth antigen.Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae.O-5S quantitative real-time PCR: a new diagnostic tool for laboratory confirmation of human onchocerciasis.Impairment of dendritic cell function by excretory-secretory products: a potential mechanism for nematode-induced immunosuppression.Onchocerca volvulus: The Road from Basic Biology to a Vaccine.Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.The Immune and Non-Immune Pathways That Drive Chronic Gastrointestinal Helminth Burdens in the Wild.Increased TGF-beta, Cbl-b and CTLA-4 levels and immunosuppression in association with chronic immune activation
P2860
Q21144551-556FD638-2385-4B1D-AD76-819AE9A54075Q28305927-ACB8DB72-8125-4EED-9F02-7A959B4317AAQ28482086-5A5555FF-8CB6-4331-BBEA-63132B113611Q28482492-7253EC69-508A-4849-8924-03C810231E2AQ28539936-BB9975FF-9B0D-49A9-9B01-CAA51B315838Q31028656-608F0521-917A-4EA3-B175-801241B2DBA5Q33258476-AF9097A8-3CA5-4ED4-82E7-D3FCB637A37EQ33518439-940865C6-0114-469D-BEB1-1961DFD8FDB6Q34058877-796FFA85-6159-45AF-BFCC-07231ECD9F32Q34194851-5808C076-02A3-4167-82E0-01B1609852AAQ34222734-BF635F12-4D85-4AF8-98A1-0D4AE9956879Q34236931-EE999ED0-EE19-4257-B75D-9CA5A86F53AFQ34729333-3016ED8C-019C-405F-8549-15DBBF17C384Q34888523-E4F97201-4A62-49CE-B5C1-68368D0E04C7Q34943271-D4928ACF-E2D8-416E-A0CB-E4F1934E560CQ35142180-1CF31AD2-92D5-4FB7-808F-7F50EE333DDAQ35619536-9A83F7E8-8844-4FB0-AA13-DD5DF3204A1DQ35744409-A2D84C06-0C52-4FE6-B161-333C76DAAEBFQ35884205-EBFB2D3C-D4F0-4DC8-AF25-B72DF76DC37AQ35920663-C4E87325-20B3-47DE-91CD-6573844EF052Q36220509-2323EF19-2AE6-46C7-AEDD-7DBEF2D3BE86Q36265018-00CA3535-F93B-41B6-97DF-C6F37CB1AFDFQ36403704-E9E304D9-B7D4-415D-ADAA-B72FA80099ECQ36441491-D0318194-039A-4250-875F-824595513BCDQ36590684-FBFD36A8-55C5-4F48-9E04-8B496A613357Q36624193-A828FD00-7ED2-4E62-89A2-79DC59B0BAD2Q37377289-768E9A0B-CE48-4A3A-A244-A4D184410935Q37491369-5B80D961-7181-4F78-935F-42E1BDDBEED1Q37582805-C0454B0B-9334-4E72-8A2D-2D85DCB30B39Q37965765-83A8A025-6E96-4046-B141-0638EFF5A2D6Q38306409-023D7AAA-B104-4F50-A643-FC3C6984123DQ39525143-E46666DE-70C6-43F7-94CB-E9F58AC56C84Q40469874-BE1EA0CA-83D4-4ED2-AABB-87E4750A6798Q41992060-7B6B8341-25C4-4DD7-99C4-8547212AFE0DQ44203897-A8A419FD-0A9F-4CD3-8D84-CAA2A5B0C8D7Q46299379-8477DE88-69FF-42B0-8BDB-1B582069508BQ46768706-A632A83A-5D36-427D-BDB1-226A2F99EB24Q47339691-EFE29909-9CE3-40A3-82E4-845381BABD70Q49829421-CBD62DBE-DEDB-4EF3-80AE-0202E7CF0E68Q56902196-4CFCF522-36DF-4A8A-9B90-4B1277FE730F
P2860
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
@ast
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
@en
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
@nl
type
label
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
@ast
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
@en
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
@nl
prefLabel
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
@ast
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
@en
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
@nl
P1476
Resistance and susceptibility in human onchocerciasis--beyond Th1 vs. Th2.
@en
P2093
Norbert Brattig
P356
10.1016/S1471-4922(01)02173-0
P577
2002-01-01T00:00:00Z